GreenMark’s dental treatments will be developed in partnership with University of Michigan, which has backed the company’s two-tranche seed round through its Mints Fund.
GreenMark Biomedical, a US-based dental treatment technology developer partly based on University of Michigan research, has closed its $1.2m seed round with a $670,000 second tranche backed by the university’s Michigan Investment in New Technology Startups (Mints) fund.
The second tranche also includes contributions from Red Cedar Ventures, a $5m VC subsidiary of Michigan State University’s nonprofit affiliate Michigan State University Foundation, and from state government-backed agency Invest Michigan.
Western Michigan University’s Biosciences Research & Commercialization Center took part in GreenMark’s initial seed tranche, as did economic development unit Invest Detroit Ventures and syndicate Blue Water Angels.
Founded in 2016, GreenMark Biomedical is working on nanoparticle-based dentistry products that help identify and treat small holes in tooth enamel before they develop into serious cavities.
The minimally-invasive products would apply bioresorbable starch-based nano-biopolymers to the teeth which dissolve into nontoxic adhesive matter by the end of…
